Spectrum Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SPPI Spectrum Pharmaceuticals Inc
NVSAW New Vista Acquisition Corp *W EXP 02/01/2026
$R25IGTRI Russell 2500 Growth TR Index
QQQ Invesco QQQ Trust
PRDO Perdoceo Education Corp
DITHF DS Smith PLC
BIOL BIOLASE Inc
GOEV Canoo Inc
CHE Chemed Corp
ASTA WorldFlix Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. Its pipeline products include ROLONTIS, Poziotinib and Anti-CD20-IFNa. ROLONTIS (eflapegrastim injection), is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib, is a pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. Anti-CD20-IFNa, is an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for treating relapsed or refractory non-Hodgkin's lymphoma (NHL) patients.

Closing Price
$1.96
Day's Change
-0.06 (-2.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.06
Day's Low
1.95
Volume
(Above Average)
Volume:
1,733,663

10-day average volume:
1,494,530
1,733,663
  • Prev Close
    2.02
  • Today's Open
    2.03
  • Day's Range
    1.95-2.06
  • Avg Vol (10-day)
    1.5M
  • Last (time)
    4:00p ET 10/15/21
  • Last (size)
    100
  • 52-Wk Range
    1.92 - 5.24
    LowHigh
  • (12/15/20 - 10/11/21)
    2.08%
  • 61.7%
  • Market Cap
    321.6M
  • Shares Outstanding
    164.1M
  • -1.29
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.0
  • 65.98
  • (% of float 09/30/21)
    11.27

Latest News

October 15, 2021
8:50 pm ET
PR Newswire
6:19 pm ET
Accesswire
5:45 pm ET
Newsfile
9:01 am ET
Accesswire
8:31 am ET
Accesswire
October 14, 2021
6:12 pm ET
Newsfile
4:40 pm ET
Newsfile
4:10 pm ET
Newsfile
2:30 pm ET
Accesswire
5:40 am ET
Accesswire
October 13, 2021
10:00 pm ET
Globe Newswire
5:30 pm ET
Accesswire
5:00 pm ET
Accesswire
4:32 pm ET
Globe Newswire
4:15 pm ET
Accesswire
4:08 pm ET
Globe Newswire
12:30 pm ET
Accesswire
October 12, 2021
12:50 pm ET
Accesswire
11:59 am ET
Globe Newswire
11:40 am ET
Accesswire
11:01 am ET
Accesswire
October 11, 2021
4:45 pm ET
Accesswire
4:14 pm ET
Globe Newswire
October 10, 2021
10:24 am ET
Newsfile
October 09, 2021
4:52 pm ET
Newsfile
10:00 am ET
BusinessWire
9:40 am ET
Globe Newswire
October 08, 2021
4:58 pm ET
Newsfile
3:10 pm ET
Accesswire
1:05 pm ET
Accesswire
12:30 pm ET
Accesswire
5:30 am ET
Accesswire
October 07, 2021
10:00 pm ET
Globe Newswire
7:29 pm ET
Accesswire
7:01 pm ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.